Martingale Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$563K Hold
24,542
0.01% 597
2025
Q1
$711K Sell
24,542
-15,663
-39% -$454K 0.02% 536
2024
Q4
$1.49M Sell
40,205
-60
-0.1% -$2.23K 0.04% 380
2024
Q3
$1.95M Buy
40,265
+1,000
+3% +$48.5K 0.04% 321
2024
Q2
$1.57M Sell
39,265
-8
-0% -$320 0.03% 353
2024
Q1
$1.72M Hold
39,273
0.03% 334
2023
Q4
$2.43M Sell
39,273
-508
-1% -$31.4K 0.05% 244
2023
Q3
$1.83M Sell
39,781
-1,782
-4% -$82K 0.04% 288
2023
Q2
$2.39M Sell
41,563
-605
-1% -$34.8K 0.05% 238
2023
Q1
$1.58M Sell
42,168
-3,980
-9% -$149K 0.03% 326
2022
Q4
$1.29M Sell
46,148
-19,388
-30% -$543K 0.03% 387
2022
Q3
$1.84M Sell
65,536
-9,038
-12% -$254K 0.04% 267
2022
Q2
$2.6M Sell
74,574
-8,562
-10% -$298K 0.05% 226
2022
Q1
$2.99M Sell
83,136
-18,866
-18% -$678K 0.04% 213
2021
Q4
$2.38M Sell
102,002
-7,985
-7% -$186K 0.03% 268
2021
Q3
$2.09M Buy
109,987
+60,570
+123% +$1.15M 0.03% 290
2021
Q2
$997K Buy
49,417
+30,000
+155% +$605K 0.01% 398
2021
Q1
$357K Sell
19,417
-300
-2% -$5.52K ﹤0.01% 705
2020
Q4
$398K Sell
19,717
-82,800
-81% -$1.67M ﹤0.01% 670
2020
Q3
$1.92M Sell
102,517
-110,313
-52% -$2.07M 0.02% 429
2020
Q2
$4.78M Buy
212,830
+13
+0% +$292 0.06% 318
2020
Q1
$3.16M Buy
212,817
+3,179
+2% +$47.2K 0.04% 394
2019
Q4
$4.05M Sell
209,638
-4,806
-2% -$92.7K 0.04% 437
2019
Q3
$4.25M Buy
214,444
+13,706
+7% +$272K 0.04% 419
2019
Q2
$4.24M Sell
200,738
-19,700
-9% -$416K 0.04% 415
2019
Q1
$4.51M Buy
220,438
+16,692
+8% +$341K 0.05% 388
2018
Q4
$4.06M Buy
203,746
+98,117
+93% +$1.95M 0.05% 369
2018
Q3
$2.03M Buy
+105,629
New +$2.03M 0.02% 549
2016
Q4
Sell
-72,903
Closed -$1.38M 958
2016
Q3
$1.38M Buy
72,903
+8,203
+13% +$156K 0.02% 604
2016
Q2
$1.04M Sell
64,700
-25,525
-28% -$411K 0.02% 488
2016
Q1
$1.08M Hold
90,225
0.02% 469
2015
Q4
$1.28M Sell
90,225
-1,597
-2% -$22.7K 0.03% 404
2015
Q3
$1.07M Buy
91,822
+63,513
+224% +$743K 0.03% 454
2015
Q2
$498K Buy
+28,309
New +$498K 0.01% 692